Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children-Reference-Cited by-同舟云学术

Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children

Published:2021-10-14 Issue:6 Volume:38 Page:1500-1505
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatric Dermatology

Author:

Parker Jennifer J.¹^ORCID,Sugarman Jeffrey L.²,Silverberg Nanette B.³^ORCID,Gonzalez Mercedes Elena⁴,Ramien Michele L.⁴,Teng Joyce M. C.⁵⁶,Paller Amy S.¹^ORCID

Affiliation:

1. Departments of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine Chicago IL USA

2. Department of Dermatology University of California San Francisco San Francisco CA USA

3. Departments of Pediatrics and Dermatology Icahn School of Medicine at Mount Sinai New York NY USA

4. Department of Dermatology University of Miami Miller School of Medicine Miami FL USA

5. Departments of Pediatrics and Medicine University of Calgary Calgary AB USA

6. Department of Dermatology Stanford University School of Medicine Stanford CA USA

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.14820

Reference20 articles.

1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

2. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

3. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

4. Adverse events of dupilumab in adults with moderate‐to‐severe atopic dermatitis: a meta‐analysis;Ou Z;Int Immunol,2018

5. Exacerbation of psoriasis after initiation of dupilumab in atopic dermatitis patient

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options;Journal of Investigative Dermatology;2024-07

2. Reacción psoriasiforme por dupilumab;Piel;2024-05

3. Entzündliche Dermatosen im Kindes- und Jugendalter;Die Dermatologie;2024-02-14

4. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

5. Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis;Pediatric Dermatology;2024-02